Carina Mari Aparici, MD


Dr. Mari Aparici is a radiologist who specializes in nuclear medicine at UCSF Medical Center. Nuclear medicine is a subspecialty of radiology that uses very small amounts of radioactive substances to examine organ function and structure. It also can be used to treat certain diseases.

Aparici earned a medical degree at the University of Valencia in Spain. She completed a doctorate in internal medicine at the Autonomous University of Barcelona as well a master's degree and a residency in nuclear medicine. At Stanford University, she completed a residency in nuclear medicine and molecular imaging, and fellowships in cardiovascular, breast and basic science molecular imaging. She has several publications and extensive research and clinical experience using PET/CT and SPET/CT techniques. Aparici is a professor in residence in the Department of Radiology and Biomedical Imaging.

Academic Title

Professor Clinical Radiology

More about Carina Mari Aparici


Universidad de Valencia School of Medicine 1992


Sant Pau Hospital School of Medicine 2000
Stanford University Medical Center 2005

Selected Research and Publications

  1. Mari Aparici C, Behr SC, Seo Y, Kelley RK, Corvera C, Gao KT, Aggarwal R, Evans MJ. Imaging Hepatocellular Carcinoma With 68Ga-Citrate PET: First Clinical Experience. Mol Imaging. 2017 Jan-Dec; 16:1536012117723256.
  2. Win A., Mari C.. Journal of Biomedical Graphics and Computing. "Heterogeneous osteoblastic activity in the right ischium of unclear etiology seen on NaF18-PET/CT". 2013; 3(1).
  3. Mari Aparici C, Seo Y. Functional imaging for prostate cancer: therapeutic implications. Semin Nucl Med. 2012 Sep; 42(5):328-42.
  4. Do BH, Mari C, Tseng JR, Quon A, Rosenberg J, Biswal S. Pattern of 18F-FDG uptake in the spinal cord in patients with non-central nervous system malignancy. Spine (Phila Pa 1976). 2011 Oct 01; 36(21):E1395-401.
  5. Taggart DR, Han MM, Quach A, Groshen S, Ye W, Villablanca JG, Jackson HA, Mari Aparici C, Carlson D, Maris J, Hawkins R, Matthay KK. Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma. J Clin Oncol. 2009 Nov 10; 27(32):5343-9.
  6. Franc BL, Acton PD, Mari C, Hasegawa BH. Small-animal SPECT and SPECT/CT: important tools for preclinical investigation. J Nucl Med. 2008 Oct; 49(10):1651-63.
  7. Iagaru A, Wang Y, Mari C, Quon A, Goris ML, Horning S, Gambhir SS. (18)F-FDG-PET/CT evaluation of response to treatment in lymphoma: when is the optimal time for the first re-evaluation scan? Hell J Nucl Med. 2008 Sep-Dec; 11(3):153-6.
  8. Seo Y, Mari C, Hasegawa BH. Technological development and advances in single-photon emission computed tomography/computed tomography. Semin Nucl Med. 2008 May; 38(3):177-98.
  9. Iagaru A, Mari C, Sam Gambhir S. Follicular dendritic sarcoma within a focus of Castleman's disease. Serial FDG PET/CT in the follow up of recurrence with histopathologic confirmation. Rev Esp Med Nucl. 2007 Jan-Feb; 26(1):40-5.
  10. Mari Aparici C. [Introduction to the molecular imaging]. Rev Esp Med Nucl. 2006 Nov-Dec; 25(6):394-409.
  11. Iagaru A, Mari C, Segall G. F-18 FDG PET evaluation of bronchial plasmacytoma with CT and MRI correlation. Clin Nucl Med. 2006 May; 31(5):279-80.
  12. Strauss HW, Mari C, Patt BE, Ghazarossian V. Intravascular radiation detectors for the detection of vulnerable atheroma. J Am Coll Cardiol. 2006 Apr 18; 47(8 Suppl):C97-100.
  13. Do B, Mari C, Biswal S, Kalinyak J, Quon A, Gambhir SS. Diagnosis of aseptic deep venous thrombosis of the upper extremity in a cancer patient using fluorine-18 fluorodeoxyglucose positron emission tomography/computerized tomography (FDG PET/CT). Ann Nucl Med. 2006 Feb; 20(2):151-5.
  14. Franc BL, Mari C, Johnson D, Leong SP. The role of a positron- and high-energy gamma photon probe in intraoperative localization of recurrent melanoma. Clin Nucl Med. 2005 Dec; 30(12):787-91.
  15. Cowan CM, Aalami OO, Shi YY, Chou YF, Mari C, Thomas R, Quarto N, Nacamuli RP, Contag CH, Wu B, Longaker MT. Bone morphogenetic protein 2 and retinoic acid accelerate in vivo bone formation, osteoclast recruitment, and bone turnover. Tissue Eng. 2005 Mar-Apr; 11(3-4):645-58.
  16. Blankenberg FG, Mandl S, Cao YA, O'Connell-Rodwell C, Contag C, Mari C, Gaynutdinov TI, Vanderheyden JL, Backer MV, Backer JM. Tumor imaging using a standardized radiolabeled adapter protein docked to vascular endothelial growth factor. J Nucl Med. 2004 Aug; 45(8):1373-80.
  17. Fong KD, Song HM, Nacamuli RP, Franc BL, Mari C, Fang TD, Warren SM, Contag CH, Blankenberg FG, Longaker MT. Apoptosis in a rodent model of cranial suture fusion: in situ imaging and gene expression analysis. Plast Reconstr Surg. 2004 Jun; 113(7):2037-47.
  18. Cowan CM, Shi YY, Aalami OO, Chou YF, Mari C, Thomas R, Quarto N, Contag CH, Wu B, Longaker MT. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol. 2004 May; 22(5):560-7.
  19. Mari C, Karabiyikoglu M, Goris ML, Tait JF, Yenari MA, Blankenberg FG. Detection of focal hypoxic-ischemic injury and neuronal stress in a rodent model of unilateral MCA occlusion/reperfusion using radiolabeled annexin V. Eur J Nucl Med Mol Imaging. 2004 May; 31(5):733-9.
  20. Mandl SJ, Mari C, Edinger M, Negrin RS, Tait JF, Contag CH, Blankenberg FG. Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome. Mol Imaging. 2004 Jan; 3(1):1-8.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.